Senesco Technologies, Inc. announced operating results for the quarter and six month periods ended December 31, 1999. 

For both the three month and six month periods, the Company reported no revenues from operations. The Company is focused on the development and commercialization of proprietary
agro-biotechnologies designed to slow the natural cellular breakdown of plants and crops due to
aging and to increase the yield of agricultural products. 

The Company reported a loss of ($488,473), or ($0.08) per share, for the three month period ended December 31, 1999, compared to a loss of ($249,051), or ($0.12) per share, for the comparative quarter ended December 31, 1998. Senesco reported a loss of ($994,804), or ($0.16) per share, for the six months ended December 31, 1999, versus a loss of ($334,230), or ($0.17) per share, for the comparative period ended December 31, 1998. 

Senesco also announced today the appointment of Richard Sirkin as Chief Financial Officer to the
Company. Mr. Sirkin brings to Senesco a highly distinguished background of more than twenty years experience in managing the accounting, budgeting, banking and information systems for emerging multinational growth companies. He will assume similar responsibilities at Senesco. 

Ruedi Stalder, Chairman and CEO of Senesco commented, ``During the past quarter, our scientific team has made significant progress in the development of our patent-pending technologies by genetically enhancing agricultural products to increase their shelf life and crop yield. The agricultural business community has shown significant interest in the Company's technologies.'' 

Mr. Stalder also commented, ``Mr. Sirkin's appointment as Chief Financial Officer is an excellent
addition to our current management team. He brings to Senesco a great deal of relevant financial
experience. We welcome him aboard as the newest member of our management team and look
forward to the contributions he will make as CFO.'' 

Senesco Technologies, Inc. is an agro-biotechnology company developing proprietary,
patent-pending genetic technologies designed to slow the rate of senescence, the natural cellular
breakdown and aging of plants and produce. The Company is exploring approaches for
implementation of the technology by conventional breeding. Senesco's technologies are applicable to prolonging the shelf life of plants and produce, and to increasing the yield of crops by enhancing their lifespan and protecting them from damaging environmental factors. 

Company news release
N2510